Case number 1:22-cv-01211
Eisai R&D Management Co., Ltd et al v. Long Grove Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 18, 2023 | 12 | NOTICE of Voluntary Dismissal by Eisai Co., Ltd., Eisai Inc., Eisai R&D Management Co., Ltd (Tigan, Jeremy) (Entered: 01/18/2023) (2) |
| Jan 18, 2023 | 13 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,965 E. (smg) (Entered: 08/04/2023) (1) |
| Dec 19, 2022 | 11 | ORDER granting 9 Motion to Appear Pro Hac Vice Appearance of Steven E. Feldman and Sherry L. Rollo. Signed by Judge William C. Bryson on 12/19/2022. (srs) (Entered: 12/19/2022) (4) |
| Dec 16, 2022 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman and Sherry L. Rollo - filed by Long Grove Pharmaceuticals, LLC. (Farnan, Kelly) (Entered: 12/16/2022) (3) |
| Dec 16, 2022 | 10 | Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Status Update - re 7 Oral Order. (Tigan, Jeremy) (Entered: 12/16/2022) (1) |
| Dec 13, 2022 | 7 | ORAL ORDER: By Friday, December 16, 2022, the plaintiffs should file a letter updating the court on the status of this case, including any efforts to serve the defendant. Signed by Judge William C. Bryson on 12/13/2022. (dds) (Entered: 12/13/2022) (0) |
| Dec 13, 2022 | 8 | WAIVER OF SERVICE returned executed by Eisai R&D Management Co., Ltd, Eisai Co., Ltd., Eisai Inc.: For Long Grove Pharmaceuticals, LLC waiver sent on 12/9/2022, answer due 2/7/2023. (Tigan, Jeremy) (Entered: 12/13/2022) (1) |
| Sep 15, 2022 | 1 | Complaint* (1) |
| Sep 15, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 09/16/2022) (3) |
| Sep 15, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/1/2022. Date of Expiration of Patent: 1/8/2027.Thirty Month Stay Deadline: 2/1/2025. (apk) (Entered: 09/16/2022) (1) |
| Sep 15, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,965 E. (apk) (Entered: 09/16/2022) (1) |
| Sep 15, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Co., Ltd. for Eisai Inc., Eisai R&D Management Co., Ltd filed by Eisai Co., Ltd., Eisai Inc., Eisai R&D Management Co., Ltd. (apk) (Entered: 09/16/2022) (1) |
| Sep 15, 2022 | 6 | Summons Issued as to Long Grove Pharmaceuticals, LLC on 9/15/2022. (apk) (Entered: 09/16/2022) (2) |
